The Role of Memantine in the Treatment of Psychiatric Disorders Other Than the Dementias: A Review of Current Preclinical and Clinical Evidence
The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.
Abstract
Memantine, a non-competitive NMDA receptor antagonist approved for Alzheimer's disease with a good safety profile, is increasingly being studied in a variety of non-dementia psychiatric disorders. We aimed to critically review relevant literature on the use of the drug in such disorders. We performed a PubMed search of the effects of memantine in animal models of psychiatric disorders and its effects in human studies of specific psychiatric disorders. The bulk of the data relates to the effects of memantine in major depressive disorder and schizophrenia, although more recent studies have provided data on the use of the drug in bipolar disorder as an add-on. Despite interesting preclinical data, results in major depression are not encouraging. Animal studies investigating the possible usefulness of memantine in schizophrenia are controversial; however, interesting findings were obtained in open studies of schizophrenia, but negative placebo-controlled, double-blind studies cast doubt on their validity. The effects of memantine in anxiety disorders have been poorly investigated, but data indicate that the use of the drug in obsessive-compulsive disorder and post-traumatic stress disorder holds promise, while findings relating to generalized anxiety disorder are rather disappointing. Results in eating disorders, catatonia, impulse control disorders (pathological gambling), substance and alcohol abuse/dependence, and attention-deficit hyperactivity disorder are inconclusive. In most psychiatric non-Alzheimer's disease conditions, the clinical data fail to support the usefulness of memantine as monotherapy or add-on treatment However, recent preclinical and clinical findings suggest that add-on memantine may show antimanic and mood-stabilizing effects in treatment-resistant bipolar disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, it also failed to affect emotional processing (facial emotion recognition and attentional vigilance to emotional words) and indeed potentiated the startle response (Sani et al. 2012, Pringle et al., 2012).”
From Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment (2021) · cites this paper as Sani et al. 2012
Citations
Cites
1 retracted
Larkin, G. L., & Beautrais, A. L. (2011) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000629 · Cited by 258
RetractedDiagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Sokoloff, L., Reivich, M., Kennedy, C., Rosiers, M. H. D., Patlak, C. S., Pettigrew, K. D., Sakurada, O., & Shinohara, M. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10649.x · Cited by 6,000
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
ADULT NEUROGENESIS IN THE MAMMALIAN CENTRAL NERVOUS SYSTEM
Ming, G.-L., & Song, H. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.051804.101459 · Cited by 1,839
Braff, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,705
Hippocampal volume and depression: a meta-analysis of MRI studies
Videbech, P., & Ravnkilde, B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.1957 · Cited by 1,590
Prestimulus Effects on Human Startle Reflex in Normals and Schizophrenics
Braff, D., Stone, C., Callaway, E., Geyer, M., Glick, I., & Bali, L. (1978) · Psychophysiology · doi:10.1111/j.1469-8986.1978.tb01390.x · Cited by 1,170
(2017) · Arzneimittelforschung · doi:10.1055/s-00000175 · Cited by 1,134
Course of illness, hippocampal function, and hippocampal volume in major depression
MacQueen, G. M., Campbell, S., McEwen, B. S., Macdonald, K., Amano, S., Joffe, R. T., Nahmias, C., & Young, L. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337481100 · Cited by 980
Spearing, M. K., Post, R. M., Leverich, G. S., Brandt, D., & Nolen, W. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(97)00123-6 · Cited by 978
Parsons, C. G., Danysz, W., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00019-2 · Cited by 878
Castrén, E., & Rantamäki, T. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20758 · Cited by 864
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
Pathological gambling is linked to reduced activation of the mesolimbic reward system
Reuter, J., Raedler, T., Rose, M., Hand, I., Gläscher, J., & Büchel, C. (2005) · Nature Neuroscience · doi:10.1038/nn1378 · Cited by 734
Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
Kim, J. S., Kornhuber, H. H., Schmid-Burgk, W., & Holzmüller, B. (1980) · Neuroscience Letters · doi:10.1016/0304-3940(80)90178-0 · Cited by 694
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
aan het Rot, M., Collins, K. A., Murrough, J. W., Perez, A. M., Reich, D. L., Charney, D. S., & Mathew, S. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.038 · Cited by 690
Price, R. B., Nock, M. K., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.029 · Cited by 600
Role of Neurotrophic Factors in the Etiology and Treatment of Mood Disorders
Duman, R. S. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:1:011 · Cited by 537
Glutamate as a therapeutic target in psychiatric disorders
Javitt, D. C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001551 · Cited by 524
The neurobiology and genetics of impulse control disorders: Relationships to drug addictions
Brewer, J. A., & Potenza, M. N. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.043 · Cited by 511
The neurobiology of pathological gambling and drug addiction: an overview and new findings
Potenza, M. N. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0100 · Cited by 508
Mechanism of action of memantine
JOHNSON, J., & KOTERMANSKI, S. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.09.007 · Cited by 502
Relapse to cocaine-seeking after hippocampal theta burst stimulation
Vorel, S. R., Liu, X., Hayes, R. J., Spector, J. A., & Gardner, E. L. (2001) · Science · doi:10.1126/science.1058043 · Cited by 486
Dunnett, S. B. (1985) · Psychopharmacology · doi:10.1007/bf00432721 · Cited by 484
Glutamatergic substrates of drug addiction and alcoholism
Gass, J. T., & Olive, M. F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.039 · Cited by 484
Seki, T., & Arai, Y. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-06-02351.1993 · Cited by 461
Verma, A., & Moghaddam, B. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00373.1996 · Cited by 449
A role for NMDA-receptor channels in working memory
Lisman, J. E., Fellous, J.-M., & Wang, X.-J. (1998) · Nature Neuroscience · doi:10.1038/1086 · Cited by 438
Course of the Manic-Depressive Cycle and Changes Caused by Treatments
Kukopulos, A., Reginaldi, D., Laddomada, P., Floris, G., Serra, G., & Tondo, L. (2008) · Pharmacopsychiatry · doi:10.1055/s-2007-1019628 · Cited by 436
Self-citationFeyissa, A. M., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.005 · Cited by 421
Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., McElroy, S. L., Keck, P. E., Kupka, R. W., Denicoff, K. D., Nolen, W. A., Grunze, H., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.232 · Cited by 419
Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E., & Meador-Woodruff, J. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301312 · Cited by 408
Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder
Berk, M., Dodd, S., Kauer‐Sant’Anna, M., Malhi, G. S., Bourin, M., Kapczinski, F., & Norman, T. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01058.x · Cited by 396
A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression
Zarate, C. A., Singh, J. B., Quiroz, J. A., De Jesus, G., Denicoff, K. K., Luckenbaugh, D. A., Manji, H. K., & Charney, D. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.153 · Cited by 387
Age-related production of new granule cells in the adult dentate gyrus
Seki, T., & Arai, Y. (1995) · NeuroReport · doi:10.1097/00001756-199512150-00010 · Cited by 385
Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat*1
MANSBACH, R. (1989) · Neuropsychopharmacology · doi:10.1016/0893-133x(89)90035-3 · Cited by 379
Management of behavioral problems in Alzheimer's disease
Gauthier, S., Cummings, J., Ballard, C., Brodaty, H., Grossberg, G., Robert, P., & Lyketsos, C. (2010) · International Psychogeriatrics · doi:10.1017/s1041610209991505 · Cited by 361
Koike, H., Iijima, M., & Chaki, S. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.05.035 · Cited by 346
Goudriaan, A. E., De Ruiter, M. B., Van Den Brink, W., Oosterlaan, J., & Veltman, D. J. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00242.x · Cited by 327
Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines
Rogawski, M. A. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90005-5 · Cited by 313
Grant, J. E., Kim, S. W., & Odlaug, B. L. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.021 · Cited by 301
Young, J. W., Powell, S. B., Risbrough, V., Marston, H. M., & Geyer, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.004 · Cited by 298
Sertraline Treatment of Pathological Gambling: A Pilot Study
Saiz-Ruiz, J., Blanco, C., Ibáñez, A., Masramon, X., Gómez, M. M., Madrigal, M., & Díez, T. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0104 · Cited by 293
The role of dopamine in bipolar disorder
Cousins, D. A., Butts, K., & Young, A. H. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00760.x · Cited by 291
Current Developments in Psychopharmacology
(1981) · Springer eBooks · doi:10.1007/978-94-011-8123-5 · Cited by 290
The role of dopamine in the mechanism of action of antidepressant drugs
D'Aquila, P. S., Collu, M., Gessa, G. L., & Serra, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00566-5 · Cited by 289
Self-citationFirst in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients
Pilowsky, L. S., Bressan, R. A., Stone, J. M., Erlandsson, K., Mulligan, R. S., Krystal, J. H., & Ell, P. J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001751 · Cited by 278
Abnormal Glutamatergic Neurotransmission and Neuronal-Glial Interactions in Acute Mania
Öngür, D., Jensen, J. E., Prescot, A. P., Stork, C., Lundy, M., Cohen, B. M., & Renshaw, P. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.014 · Cited by 270
Tsai, G., & Lin, P.-Y. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361452 · Cited by 269
MacDonald, J. F., Bartlett, M. C., Mody, I., Pahapill, P., Reynolds, J. N., Salter, M. W., Schneiderman, J. H., & Pennefather, P. S. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018396 · Cited by 266
The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder
Wu, K., Hanna, G. L., Rosenberg, D. R., & Arnold, P. D. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.10.007 · Cited by 264
Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism
Nevo, I. (1995) · Neurochemistry International · doi:10.1016/0197-0186(94)00139-l · Cited by 263
Randrup, A., & Br�strup, C. (1977) · Psychopharmacology · doi:10.1007/bf00492370 · Cited by 263
Modification of the startle reflex in the rat by changes in the auditory and visual environments.
Ison, J. R., & Hammond, G. R. (1971) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0030934 · Cited by 257
Mania associated with antidepressant treatment: comprehensive meta‐analytic review
Tondo, L., Vázquez, G., & Baldessarini, R. J. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01514.x · Cited by 256
Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex
Kornhuber, J., Bormann, J., Retz, W., Hübers, M., & Riederer, P. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90384-1 · Cited by 253
A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior
Cornish, J. L., Duffy, P., & Kalivas, P. W. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00214-6 · Cited by 249
Increased cerebrospinal fluid glutamine levels in depressed patients
Levine, J., Panchalingam, K., Rapoport, A., Gershon, S., McClure, R. J., & Pettegrew, J. W. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00284-x · Cited by 240
Spyraki, C., & Fibiger, H. C. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90531-8 · Cited by 239
Maeng, S., & Zarate, C. A. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0063-1 · Cited by 229
Winstanley, C. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01323.x · Cited by 218
Adamec, R. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00055-3 · Cited by 218
The role of dopamine in mood disorders
Diehl, D. J., & Gershon, S. (1992) · Comprehensive Psychiatry · doi:10.1016/0010-440x(92)90007-d · Cited by 216
Glutamatergic medications for the treatment of drug and behavioral addictions
Olive, M. F., Cleva, R. M., Kalivas, P. W., & Malcolm, R. J. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.015 · Cited by 210
Serra, G., Argiolas, A., Klimek, V., Fadda, F., & Gessa, G. L. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90573-3 · Cited by 192
Self-citationThe NMDA Receptor Hypofunction Model of Psychosis
FARBER, N. B. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.008 · Cited by 190
Increased serum glutamate in depressed patients
Kim, J. S., Schmid-Burgk, W., Claus, D., & Kornhuber, H. H. (1982) · Archiv f�r Psychiatrie und Nervenkrankheiten · doi:10.1007/bf00345492 · Cited by 189
Modulation of learning processes by ionotropic glutamate receptor ligands
Danysz, W., Zajaczkowski, W., & Parsons, C. G. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199508000-00007 · Cited by 185
Pharmacodynamics of Memantine: An Update
Parsons, C., Rammes, G., & Danysz, W. (2008) · Current Neuropharmacology · doi:10.2174/157015908783769671 · Cited by 183
Xiu, M. H., Hui, L., Dang, Y. F., De Hou, T., Zhang, C. X., Zheng, Y. L., Chen, D. C., Kosten, T. R., & Zhang, X. Y. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.011 · Cited by 173
Hill, S. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00213-5 · Cited by 168
Review of Adjunctive Glutamate Antagonist Therapy in the Treatment of Catatonic Syndromes
Carroll, B. T., Goforth, H. W., Thomas, C., Ahuja, N., McDaniel, W. W., Kraus, M. F., Spiegel, D. R., Franco, K. N., Pozuelo, L., & Munoz, C. (2007) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.19.4.406 · Cited by 163
Hotsenpiller, G., Giorgetti, M., & Wolf, M. E. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01804.x · Cited by 162
for the MEM-MD-29 Study Group, Lieberman, J. A., Papadakis, K., Csernansky, J., Litman, R., Volavka, J., Jia, X. D., & Gage, A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.200 · Cited by 162
Grant, J. E., Odlaug, B. L., Potenza, M. N., Hollander, E., & Kim, S. W. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.078105 · Cited by 162
A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder
Stewart, S. E., Jenike, E. A., Hezel, D. M., Stack, D. E., Dodman, N. H., Shuster, L., & Jenike, M. A. (2010) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181c856de · Cited by 158
Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine
Mansbach, R. S., & Geyer, M. A. (1991) · Psychopharmacology · doi:10.1007/bf02244303 · Cited by 151
Nudmamud‐Thanoi, S., & Reynolds, G. P. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.035 · Cited by 150
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans
Bisaga, A. M., Comer, S. D., Ward, A. S., Popik, P., Kleber, H. D., & Fischman, M. W. (2001) · Psychopharmacology · doi:10.1007/s002130100739 · Cited by 145
Hill, S. K., Beers, S. R., Kmiec, J. A., Keshavan, M. S., & Sweeney, J. A. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00125-7 · Cited by 141
Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: An Open-Label Trial
Aboujaoude, E., Barry, J. J., & Gamel, N. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318192e9a4 · Cited by 136
Barch, D. M., Carter, C. S., Arnsten, A., Buchanan, R. W., Cohen, J. D., Geyer, M., Green, M. F., Krystal, J. H., Nuechterlein, K., Robbins, T., et al. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn163 · Cited by 133
de Lucena, D. F., Fernandes, B. S., Berk, M., Dodd, S., Medeiros, D. W., Pedrini, M., Kunz, M., Gomes, F. A., Giglio, L. M. F., Lobato, M. I. R., et al. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04935gry · Cited by 133
Carlsson, M. L. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00146-9 · Cited by 132
Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation
Duncan, G. E., Leipzig, J. N., Mailman, R. B., & Lieberman, J. A. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00926-3 · Cited by 132
Antiglutamatergic Strategies for Ethanol Detoxification: Comparison With Placebo and Diazepam
Krupitsky, E. M., Rudenko, A. A., Burakov, A. M., Slavina, T. Y., Grinenko, A. A., Pittman, B., Gueorguieva, R., Petrakis, I. L., Zvartau, E. E., & Krystal, J. H. (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00344.x · Cited by 130
Gray, L., van den Buuse, M., Scarr, E., Dean, B., & Hannan, A. J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009085 · Cited by 130
Bræstrup, C., Andersen, H., & Randrup, A. A. (1975) · European Journal of Pharmacology · doi:10.1016/0014-2999(75)90238-1 · Cited by 127
Neurocognitive allied phenotypes for schizophrenia and bipolar disorder
Hill, S. K., Harris, M. S. H., Herbener, E. S., Pavuluri, M., & Sweeney, J. A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn027 · Cited by 123
CNTRICS Final Task Selection: Working Memory
Barch, D. M., Berman, M. G., Engle, R., Jones, J. H., Jonides, J., MacDonald, A., Nee, D. E., Redick, T. S., & Sponheim, S. R. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn153 · Cited by 121
Memantine agonist action at dopamine D2High receptors
Seeman, P., Caruso, C., & Lasaga, M. (2008) · Synapse · doi:10.1002/syn.20472 · Cited by 120
Réus, G. Z., Stringari, R. B., Kirsch, T. R., Fries, G. R., Kapczinski, F. P., Roesler, R., & Quevedo, J. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.11.013 · Cited by 119
Glutamate and GABA in lateral hypothalamic mechanisms controlling food intake
Stanley, B. G., Urstadt, K. R., Charles, J. R., & Kee, T. W. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.046 · Cited by 119
Smith, J. W., Gastambide, F., Gilmour, G., Dix, S. L., Foss, J., Lloyd, K. G., Malik, N. K., & Tricklebank, M. D. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2277-5 · Cited by 118
Muhonen, L. H., Lonnqvist, J., Juva, K., & Alho, H. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0308 · Cited by 118
Pharmacokinetic study of memantine in healthy and renally impaired subjects
Periclou, A. P., Ventura, D., RAO, N., & Abramowitz, W. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.10.005 · Cited by 118
Dorval, K. M., Wigg, K. G., Crosbie, J., Tannock, R., Kennedy, J. L., Ickowicz, A., Pathare, T., Malone, M., Schachar, R., & Barr, C. L. (2007) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2006.00273.x · Cited by 117
Striatal Creatine and Glutamate/Glutamine in Attention-Deficit/Hyperactivity Disorder
Carrey, N. J., MacMaster, F. P., Gaudet, L., & Schmidt, M. H. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0008 · Cited by 117
Effect of Memantine on Cue-Induced Alcohol Craving in Recovering Alcohol-Dependent Patients
Krupitsky, E. M., Neznanova, O., Masalov, D., Burakov, A. M., Didenko, T., Romanova, T., Tsoy, M., Bespalov, A., Slavina, T. Y., Grinenko, A. A., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.3.519 · Cited by 116
A systematic review of off-label uses of memantine for psychiatric disorders
Zdanys, K. F., & Tampi, R. R. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.01.008 · Cited by 115
An open-label, flexible-dose study of memantine in major depressive disorder
Ferguson, J. M., & Shingleton, R. N. (2007) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3180314ae7 · Cited by 113
Russell, V. A. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.010 · Cited by 107
Perlov, E., Philipsen, A., Heßlinger, B., Büchert, M., Ahrendts, J., Feige, B., Bubl, E., Hennig, J., Ebert, D., & van Elst, L. T. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.12.007 · Cited by 105
Rogawski, M. A. (2000) · Amino Acids · doi:10.1007/s007260070042 · Cited by 105
A Pilot Double‐Blind Treatment Trial of Memantine for Alcohol Dependence
Evans, S. M., Levin, F. R., Brooks, D. J., & Garawi, F. (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00360.x · Cited by 101
Turic, D., Langley, K., Mills, S., Stephens, M., Lawson, D. C., Govan, C., Williams, N. M., van den Bree, M. B. M., Craddock, N. J., Kent, L., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001387 · Cited by 101
Memantine for Treatment-Resistant OCD
Poyurovsky, M., Weizman, R., Weizman, A., & Koran, L. M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2191-a · Cited by 101
Farlow, M. R., Graham, S. M., & Alva, G. (2008) · Drug Safety · doi:10.2165/00002018-200831070-00003 · Cited by 101
Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats
Meloni, D., Gambarana, C., Montis, M. G. D., Pra, P. D., Taddei, I., & Tagliamonte, A. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90374-3 · Cited by 100
Memantine augmentation for refractory obsessive–compulsive disorder
Pasquini, M., & Biondi, M. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.04.013 · Cited by 100
Egashira, N., Okuno, R., Harada, S., Matsushita, M., Mishima, K., Iwasaki, K., Nishimura, R., Oishi, R., & Fujiwara, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.035 · Cited by 100
Serra, G., Collu, M., D’Aquila, P. S., Montis, M. G. D., & GESSA, G. L. (1990) · Brain Research · doi:10.1016/0006-8993(90)91142-4 · Cited by 97
Self-citationCarlsson, M. L. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.102006401.x · Cited by 96
Vandergriff, J. L., & Rasmussen, K. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00196-8 · Cited by 95
Quan, M., Zhang, N., Wang, Y.-Y., Zhang, T., & Yang, Z. R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.026 · Cited by 92
Reddy, D. S., & Kulkarni, S. K. (1998) · Psychopharmacology · doi:10.1007/s002130050635 · Cited by 91
Feusner, J. D., Kerwin, L., Saxena, S., & Bystritsky, A. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4096 · Cited by 91
Hill, S. K., Ragland, J. D., Gur, R. C., & Gur, R. E. (2002) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.24.6.765.8402 · Cited by 90
Gilmour, G., Pioli, E. Y., Dix, S. L., Smith, J. W., Conway, M. W., Jones, W. T., Loomis, S., Mason, R., Shahabi, S., & Tricklebank, M. D. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1530-7 · Cited by 89
Acute effects of memantine in combination with alcohol in moderate drinkers
Bisaga, A. M., & Evans, S. M. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1617-5 · Cited by 87
Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions
Mills, I. (1998) · QJM · doi:10.1093/qjmed/91.7.493 · Cited by 87
Jensen, V., Rinholm, J. E., Johansen, T., Medin, T., Storm‐Mathisen, J., Sagvolden, T., Hvalby, Ø., & Bergersen, L. H. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.016 · Cited by 87
The primacy of mania: A reconsideration of mood disorders
Koukopoulos, A., & Ghaemi, S. N. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2008.07.006 · Cited by 84
Incipient Neurovulnerability and Neuroprotection in Early Psychosis
Berger, G. E., MD, (CH), F. P., Wood, S., (Cantab), M., PhD, McGorry, A. P. D., MBBS, MD, PhD, et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4186 · Cited by 82
Larkin, G. L., Beautrais, A. L., Turelli, R. R., Sanacora, G., Powsner, S., Lippmann, M., & Krystal, J. (2011) · European Psychiatry · doi:10.1016/s0924-9338(11)73311-9 · Cited by 80
Lack of Pharmacokinetic or Pharmacodynamic Interaction Between Memantine and Donepezil
Periclou, A. P., Ventura, D., Sherman, T., Rao, N., & Abramowitz, W. T. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d638 · Cited by 80
Evidence for a role for GABAA and NMDA receptors in ethanol inhibition of long-term potentiation
Schummers, J., & Browning, M. D. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00161-9 · Cited by 79
Effects of Sustained Phencyclidine Exposure on Sensorimotor Gating of Startle in Rats
Martinez, Z. A., Ellison, G. D., Geyer, M. A., & Swerdlow, N. R. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00137-7 · Cited by 77
Findling, R. L., McNamara, N. K., Stansbrey, R. J., Maxhimer, R., Periclou, A., Mann, A., & Graham, S. M. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0044 · Cited by 76
A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors
Jones, R. W. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2384 · Cited by 75
Serra, G., Argiolas, A., Fadda, F., & Gessa, G. L. (1980) · Pharmacological Research Communications · doi:10.1016/s0031-6989(80)80149-4 · Cited by 75
Self-citationPACCHIONI, A. M., GIOINO, G., ASSIS, A., & CANCELA, L. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04165.x · Cited by 74
Gessa, G. L., Pani, L., Serra, G., & Fratta, W. (1995) · PubMed · Cited by 73
Self-citationNamba, T., Ming, G., Song, H., Waga, C., Enomoto, A., Kaibuchi, K., Kohsaka, S., & Uchino, S. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07282.x · Cited by 70
Effects of NMDA receptor ligands on sensorimotor gating in the rat
Mansbach, R. S. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90253-m · Cited by 70
Adams, J., Crosbie, J., Wigg, K., Ickowicz, A., Pathare, T., Roberts, W., MALONE, M. A., Schachar, R. J., Tannock, R., Kennedy, J. L., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001455 · Cited by 69
Lehohla, M., Kellaway, L. A., & Russell, V. A. (2004) · Metabolic Brain Disease · doi:10.1023/b:mebr.0000027415.75432.ad · Cited by 69
Cerebrospinal Fluid Amino Acids in Pathological Gamblers and Healthy Controls
Nordin, C., Gupta, R. C., & Sjödin, I. (2007) · Neuropsychobiology · doi:10.1159/000115782 · Cited by 69
Hayes, R. J., Vorel, S. R., Spector, J. A., Liu, X., & Gardner, E. L. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1328-3 · Cited by 68
Wang, T., O'Connor, W. T., Ungerstedt, U., & French, E. D. (1994) · Brain Research · doi:10.1016/0006-8993(94)90780-3 · Cited by 67
Liu, M., Meng, S., Wu, H., Wang, S., & Wei, M. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.04.005 · Cited by 67
Anand, A., Gunn, A. D., Barkay, G., Karne, H. S., Nurnberger, J. I., Mathew, S. J., & Ghosh, S. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00971.x · Cited by 65
The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality
Trujillo, K. A., & Akil, H. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90032-w · Cited by 65
Memantine in the treatment of binge eating disorder: An open‐label, prospective trial
Brennan, B. P., Roberts, J. L., Fogarty, K. V., Reynolds, K. A., Jonas, J. M., & Hudson, J. I. (2008) · International Journal of Eating Disorders · doi:10.1002/eat.20541 · Cited by 64
Broadbent, J., Kampmueller, K. M., & Koonse, S. A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1404-3 · Cited by 63
Memantine Pharmacotherapy: A Naturalistic Study Using a Population Pharmacokinetic Approach
Kornhuber, J., Kennepohl, E. M., Bleich, S., Wiltfang, J., Kraus, T., Reulbach, U., & Meineke, I. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746070-00005 · Cited by 63
Koukopoulos, A., Serra, G., Koukopoulos, A. E., Reginaldi, D., & Serra, G. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.09.040 · Cited by 62
Self-citationThe Effects of Memantine on Prepulse Inhibition
Swerdlow, N. R., van Bergeijk, D. P., Bergsma, F., Weber, E., & Talledo, J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.7 · Cited by 61
Krivoy, A., Weizman, A., Tatsa-Laur, L., Hellinger, N., Zemishlany, Z., & Fischel, T. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.07.008 · Cited by 61
Bisaga, A. M., Danysz, W., & Foltin, R. W. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.05.004 · Cited by 61
Bisaga, A., Aharonovich, E., Cheng, W. Y., Levin, F. R., Mariani, J. J., Raby, W. N., & Nunes, E. V. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.04.006 · Cited by 59
Depression and mania : from neurobiology to treatment
Gessa, G. L., Costa, E., & Greengard, P. (1995) · Raven Press eBooks · Cited by 58
ROLE OF THE MESOLIMBIC DOPAMINE SYSTEM IN THE MECHANISM OF ACTION OF ANTIDEPRESSANTS
Serra, G., Collu, M., D’Aquila, P. S., & Gessa, G. L. (1992) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1992.tb01631.x · Cited by 58
Self-citationMemantine and Catatonic Schizophrenia
THOMAS, C., Carroll, B. T., Maley, R. T., Jayanti, K., & Koduri, A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.3.626 · Cited by 57
Catatonic Schizophrenia and the Use of Memantine
Carpenter, S. S., HATCHETT, A. D., & Fuller, M. A. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g297 · Cited by 57
Memantine as an Augmenting Agent for Severe Pediatric OCD
HEZEL, D. M., BEATTIE, K., & STEWART, S. E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08091427 · Cited by 55
Rapid Cyclers and Antidepressants
Tondo, L., Laddomada, P., Serra, G., Minnai, G., & Kukopulos, A. (1981) · International Pharmacopsychiatry · doi:10.1159/000468483 · Cited by 55
Self-citationBehavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats
Collu, M., Poggiu, A. S., Devoto, P., & Serra, G. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00006-x · Cited by 55
Self-citationCollins, E. D., Ward, A. S., McDowell, D. M., Foltin, R. W., & Fischman, M. W. (1998) · Behavioural Pharmacology · doi:10.1097/00008877-199811000-00014 · Cited by 54
Excitatory Amino Acid Neurotransmission
Zieglgänsberger, W., Parsons, C. G., & Danysz, W. (2005) · Springer eBooks · doi:10.1007/3-540-28082-0_10 · Cited by 52
Keck, P. E., Hsu, H.-A., Papadakis, K., & Russo, J. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318184fae2 · Cited by 51
Glutamate and psychiatric disorders
Tsapakis, E.-M., & Travis, M. J. (2002) · Advances in Psychiatric Treatment · doi:10.1192/apt.8.3.189 · Cited by 51
Memantine and Catatonia: A Case Report and Literature Review
Obregon, D. F., Velasco, R. M., Wuerz, T. P., Catalano, M. C., Catalano, G., & Kahn, D. A. (2011) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000400268.60537.5e · Cited by 50
Pozzi, L., Baviera, M., Sacchetti, G., Calcagno, E., Balducci, C., Invernizzi, R. W., & Carli, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.060 · Cited by 49
Carrey, N., MacMaster, F. P., Sparkes, S. J., Khan, S. C., & Kusumakar, V. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602762599871 · Cited by 49
[Pharmacodynamics and pharmacokinetics of memantine].
Wesemann, W., Sontag, K. ‐., & Maj, J. (1983) · PubMed · Cited by 49
Tokuyama, S., Zhu, H., Oh, S., Ho, I. K., & Yamamoto, T. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00019-5 · Cited by 49
Hermanussen, M., & Tresguerres, J. A. F. (2005) · Economics & Human Biology · doi:10.1016/j.ehb.2005.04.001 · Cited by 48
NMDA, kainate, and AMPA depolarize nondopamine neurons in the rat ventral tegmentum
Wang, T., & French, E. D. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(94)00160-3 · Cited by 48
Pilot Trial of Memantine in the Treatment of Posttraumatic Stress Disorder
Battista, M. A., Hierholzer, R., Khouzam, H. R., Barlow, A., & O'Toole, S. (2007) · Psychiatry: Interpersonal and Biological Processes · doi:10.1521/psyc.2007.70.2.167 · Cited by 47
Harvey, B. H., Bothma, T., Nel, A., Wegener, G., & Stein, D. J. (2005) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.695 · Cited by 47
Memantine reduces consumption of highly palatable food in a rat model of binge eating
Popik, P., Kos, T., Zhang, Y., & Bisaga, A. (2011) · Amino Acids · doi:10.1007/s00726-010-0659-3 · Cited by 46
Nakagawa, T., Suzuki, Y., Nagayasu, K., Kitaichi, M., Shirakawa, H., & Kaneko, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024865 · Cited by 45
Koukopoulos, A., Reginaldi, D., Serra, G., KOUKOPOULOS, A., Sani, G., & Serra, G. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00803.x · Cited by 43
Self-citationMuhonen, L. H., Lahti, J., Sinclair, D., Lönnqvist, J., & Alho, H. (2008) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/1747-597x-3-20 · Cited by 42
Wang, H., Zhao, Y., Xiang, X., Wang, H., & Wu, W.-R. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.043 · Cited by 41
Kelamangalath, L., Swant, J., Stramiello, M., & Wagner, J. J. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.08.001 · Cited by 40
Warton, F. L., Howells, F. M., & Russell, V. A. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-009-9166-1 · Cited by 39
Dedeurwaerdere, S., Wintmolders, C., Straetemans, R., Pemberton, D. J., & Langlois, X. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2052-z · Cited by 38
Kollmar, R., Markovic, K., Thürauf, N., Schmitt, H., & Kornhuber, J. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701787628 · Cited by 37
Memantine reduces mania-like symptoms in animal models
Gao, Y., Payne, R. S., Schurr, A., Hougland, M. T., Lord, J., Herman, L., Lei, Z. M., Banerjee, P., & El‐Mallakh, R. S. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.12.030 · Cited by 36
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence
Bisaga, A. M., Sullivan, M. A., Cheng, W. Y., Carpenter, K. M., Mariani, J. J., LEVIN, F. R., Raby, W. N., & Nunes, E. V. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.05.019 · Cited by 36
Nadler, V., Kloog, Y., & Sokolovsky, M. (1990) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(90)90044-x · Cited by 36
Dannon, P. N., Lowengrub, K., Gonopolski, Y., Musin, E., & Kotler, M. (2006) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v08n0603 · Cited by 35
Long-term imipramine withdrawal induces a depressive-like behaviour in the forced swimming test
D’Aquila, P. S., Panin, F., & Serra, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.008 · Cited by 34
Self-citationYao, C., Raoufinia, A., Gold, M., Nye, J. S., Ramael, S., Padmanabhan, M., Walschap, Y., Verhaeghe, T., & Zhao, Q. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005274551 · Cited by 34
D’Aquila, P. S., Peana, A. T., Panin, F., Grixoni, C., Cossu, M. L., & Serra, G. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02731-0 · Cited by 34
Self-citationRasmussen, K., Hsu, M.-A., & Vandergriff, J. L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.013 · Cited by 33
Physiology and pathology of NMDA receptors.
Petrović, M., Hořák, M., Sedlacek, M., & Vyklický, L. (2005) · PubMed · Cited by 33
Shua‐Haim, J. R., Smith, J. M., Picard, F., Sedek, G., Athalye, S. N., Pommier, F., & Lefèvre, G. Y. (2008) · Clinical Drug Investigation · doi:10.2165/00044011-200828060-00004 · Cited by 32
Sukhanov, I., Захарова, Е. С., Danysz, W., & Bespalov, A. (2004) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000137212.03247.f1 · Cited by 29
Tsuda, M., Suzuki, T., & Misawa, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00052-3 · Cited by 28
Wiley, J. L., Harvey, S. A., Balster, R. L., & Nicholson, K. L. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1297-6 · Cited by 28
Muhonen, L. H., Lönnqvist, J. K., Lahti, J. M. T., & Alho, H. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.05.001 · Cited by 28
Research works printed but not linked: 8
- Dingledine, 1999, Pharmacol Rev, 51, 7
- Danysz, 1995, Behav Pharmacol, 6, 455
- Petrović, 2005, Prague Med Rep, 106, 113
- Berger, 2003, Psychopharmacol Bull, 37, 79
- Feusner, 2009, Psychopharmacology Bull, 42, 81
- Roncero, 2009, Actas Esp Psiquiatr, 37, 205
- Grant, 2011, Erratum in: Br J Psychiatry, 198, 75
- Parsons, 2005, Handb Exp Pharmacol, &NA;, 249
Cited by
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., & Iosifescu, D. V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.595584 · Cited by 440
“Memantine, an NMDA receptor antagonist FDA-approved for the treatment of Alzheimer dementia, moderate-severe, was tested previously in preclinical studies as a potential antidepressant (168).”
BackgroundMemantine for Alzheimer’s Disease: An Updated Systematic Review and Meta-analysis
Kishi, T., Matsunaga, S., Oya, K., Nomura, I., Ikuta, T., & Iwata, N. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170424 · Cited by 249
Sanacora, G., & Schatzberg, A. F. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.261 · Cited by 160
Godlewska, B. R., & Harmer, C. J. (2021) · Psychopharmacology · doi:10.1007/s00213-019-05448-0 · Cited by 123
Recent insights into the mode of action of memantine and ketamine
Johnson, J. W., Glasgow, N. G., & Povysheva, N. V. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.11.006 · Cited by 116
Metadata
- Authors
- Sani, G., Serra, G., Kotzalidis, G. D., Romano, S., Tamorri, S. M., Manfredi, G., Caloro, M., Telesforo, C. L., Caltagirone, S. S., Panaccione, I., Simonetti, A., Demontis, F., Serra, G., & Girardi, P.
- Affiliations
- Azienda Ospedaliera Sant'Andrea (IT)
- University of Sassari (IT)
- Corresponding author
- Sani, Gabriele
- ORCID
- Venue
- CNS Drugs
- Published
- 2012-08
- Volume
- 26
- Issue
- 8
- Pages
- 663-690
- ISSN
- 1172-7047 (ISSN-L)
- OpenAlex
- W1524631360
- Cited by
- 273
- References
- 238
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 8 · 2021: 6 · 2020: 160 · 2019: 7 · 2018: 7 · 2017: 8 · 2016: 11 · 2015: 17 · 2014: 19 · 2013: 14
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS Drugs (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- memantine, NMDA receptor antagonists, major depressive disorder, schizophrenia, bipolar disorder, obsessive-compulsive disorder, post-traumatic stress disorder, generalized anxiety disorder, eating disorders, catatonia, impulse control disorders, substance use disorders, alcoholism, attention deficit hyperactivity disorder, adjunctive therapy, treatment-resistant bipolar disorder, mood stabilization
- MeSH terms
- Animals, Mental Disorders, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Memantine, Treatment Outcome, Excitatory Amino Acid Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.